These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1549810)

  • 1. Cyclo-oxygenase inhibitors in ophthalmology.
    Flach AJ
    Surv Ophthalmol; 1992; 36(4):259-84. PubMed ID: 1549810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical nonsteroidal antiinflammatory drugs in ophthalmology.
    Flach AJ
    Int Ophthalmol Clin; 2002; 42(1):1-11. PubMed ID: 12189605
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of NSAIDs in the management of postoperative ophthalmic inflammation.
    Colin J
    Drugs; 2007; 67(9):1291-308. PubMed ID: 17547472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on clinical pathophysiology of pseudophakic/aphakic eyes--a journey of 4 decades].
    Miyake K
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):214-45; discussion 246. PubMed ID: 18411712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory agents in cataract intraocular lens surgery.
    Miyake K
    Curr Opin Ophthalmol; 1995 Feb; 6(1):62-5. PubMed ID: 10150847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.
    Flach AJ; Dolan BJ; Irvine AR
    Am J Ophthalmol; 1987 Apr; 103(4):479-86. PubMed ID: 3551617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic therapy of aphakic and pseudophakic cystoid macular edema. 1985 update.
    Jampol LM
    Ophthalmology; 1985 Jun; 92(6):807-10. PubMed ID: 3897936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
    Weisz JM; Bressler NM; Bressler SB; Schachat AP
    Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cataract surgery and nonsteroidal antiinflammatory drugs.
    Hoffman RS; Braga-Mele R; Donaldson K; Emerick G; Henderson B; Kahook M; Mamalis N; Miller KM; Realini T; Shorstein NH; Stiverson RK; Wirostko B;
    J Cataract Refract Surg; 2016 Sep; 42(9):1368-1379. PubMed ID: 27697257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 0.1% Indomethacin eyedrops on cataract surgery.
    Liou SW; Yen RJ
    J Ocul Pharmacol; 1991; 7(1):77-81. PubMed ID: 2061692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. Italian Diclofenac Study Group.
    J Cataract Refract Surg; 1997 Oct; 23(8):1183-9. PubMed ID: 9368162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis.
    Rossetti L; Chaudhuri J; Dickersin K
    Ophthalmology; 1998 Mar; 105(3):397-405. PubMed ID: 9499767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review.
    Kessel L; Tendal B; Jørgensen KJ; Erngaard D; Flesner P; Andresen JL; Hjortdal J
    Ophthalmology; 2014 Oct; 121(10):1915-24. PubMed ID: 24935281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrating keratoplasty combined with extracapsular cataract extraction.
    Kramer SG
    Am J Ophthalmol; 1985 Jul; 100(1):129-33. PubMed ID: 3893136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative antibiotic, steroidal, and nonsteroidal anti-inflammatory agents in cataract intraocular lens surgery.
    Abel R; Abel AD
    Curr Opin Ophthalmol; 1996 Feb; 7(1):39-42. PubMed ID: 10160434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of pseudophakic cystoid macular edema].
    Agostini HT; Hansen LL; Feltgen N
    Ophthalmologe; 2007 May; 104(5):425-6, 428-30. PubMed ID: 17443332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine Use of Nonsteroidal Anti-inflammatory Drugs with Corticosteroids in Cataract Surgery: Beneficial or Redundant?
    Kim SJ; Patel SN; Sternberg P
    Ophthalmology; 2016 Mar; 123(3):444-6. PubMed ID: 26902558
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of macular oedema in diabetic patients undergoing cataract surgery.
    Boscia F; Giancipoli E; D'Amico Ricci G; Pinna A
    Curr Opin Ophthalmol; 2017 Jan; 28(1):23-28. PubMed ID: 27661663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
    Pollack A; Staurenghi G; Sager D; Mukesh B; Reiser H; Singh RP
    Br J Ophthalmol; 2017 Apr; 101(4):423-427. PubMed ID: 27388251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.